BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28160142)

  • 1. Patterns, Predictive Factors, and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma.
    Kim SK; Park I; Hur N; Rayzah M; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2017 Jul; 24(7):1943-1950. PubMed ID: 28160142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
    Back K; Kim JS; Kim JH; Choe JH
    Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma.
    Kim SK; Kwon AY; Back K; Park I; Hur N; Lee JH; Choe JH; Kim JH; Oh YL; Kim JS
    Ann Surg Oncol; 2017 Sep; 24(9):2617-2623. PubMed ID: 28685355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Level 2b Dissection may be Recommended Only in N1b Papillary Thyroid Carcinoma with Three- or Four-Level Lateral Lymph Node Metastasis.
    Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):694-700. PubMed ID: 27654111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns, predictive factors and prognostic impact of multilevel metastasis in N1b papillary thyroid carcinoma.
    Kim SK; Park I; Hur N; Choe JH; Kim JH; Kim JS
    Br J Surg; 2017 Jun; 104(7):857-867. PubMed ID: 28295219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2016 Sep; 23(9):2866-73. PubMed ID: 27075321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
    Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b.
    Gao L; Li X; Xia Y; Liu R; Liu C; Shi X; Wu Y; Ma L; Jiang Y
    Front Endocrinol (Lausanne); 2021; 12():815207. PubMed ID: 35185788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.
    Koo BS; Choi EC; Park YH; Kim EH; Lim YC
    J Am Coll Surg; 2010 Jun; 210(6):895-900. PubMed ID: 20510797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
    Back K; Choe JH; Kim JS; Kim JH
    Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.